Evaluation of the effect of zinc sulfate in improving the symptoms of schizophrenia patients
Phase 3
Recruiting
- Conditions
- Schizophrenia.Schizophrenia
- Registration Number
- IRCT20200815048417N1
- Lead Sponsor
- Ahvaz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 88
Inclusion Criteria
Patients with schizophrenia treated with atypical antipsychotic drugs
Written consent to study
The patient is able to take medicine
Exclusion Criteria
Organic disease
Existance of other disorders such as mental retardation or cognitive problems
Need to receive electric shock
Allergy to zinc sulfate
Pregnant patients
Dependance and substance use
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The effect of Zinc sulfate on the symptoms of Schizophrenia according to the PANSS ( positive and negative and psychopathology symptoms ) questionnaire. Timepoint: At the beginning of the study ( before the intervention ), the second week , the fourth week and the sixth week after starting Zinc sulfate consumption. Method of measurement: Positive and negative and psychopathology symptoms questionnaire.
- Secondary Outcome Measures
Name Time Method